Lakewood-Amedex Biotherapeutics

LABT · NASDAQ

$0.5775+$0.0002 (+0.03%)TodayMarket closed ·
Prev close $0.5773

Who owns LABT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 55.6% of LABT’s shares.

  • HPW Investments Holdings, Ltd.19.6%
  • Lindesfarne, L.L.C.13.2%
  • WFI Equity, L.L.C.7.2%
  • TLP Management, Inc.4.5%
  • Next 6 largest institutions11.1%
  • All other shareholders44.4%
Top institutional holders of LABT
HolderShares% of shares
HPW Investments Holdings, Ltd.343.55K19.63%
Lindesfarne, L.L.C.231.00K13.20%
WFI Equity, L.L.C.125.97K7.20%
TLP Management, Inc.77.95K4.45%
Brown (Ted Jr.)77.55K4.43%
Marex Group plc48.17K2.75%
HRT Financial LP44.78K2.56%
Ceccacci (Peter)11.13K0.64%
DeRoma (Leonard J.)7.46K0.43%
Manion (Doug M.D.)5.18K0.30%

Largest mutual fund holders

Top mutual fund holders of LABT
HolderShares% of shares
Fidelity Extended Market Index Fund1.49K0.09%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of LABT in the last 6 months.

Latest LABT insider transactions
InsiderTypeSharesValue
Tucker Joseph EdwardAward33.78K—

Short interest

Settled Sep 30, 2026

Shares short
130.72K
Days to cover
1.00
% of shares outstanding
7.47%
Average daily volume
3.34M
Change since last report
+146.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.